Results 251 to 260 of about 752,560 (269)

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

Nature Reviews Clinical Oncology, 2022
Wolf H Fridman, Maxime Meylan, Florent Petitprez   +2 more
exaly  

Intratumoural administration and tumour tissue targeting of cancer immunotherapies

Nature Reviews Clinical Oncology, 2021
Ignacio Melero Bermejo, Eduardo Castanon, Maite Alvarez   +2 more
exaly  

The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities

Nature Reviews Clinical Oncology, 2020
Won Jin Ho, Elizabeth M Jaffee, Lei Zheng   +2 more
exaly  

Therapeutic targeting of the hypoxic tumour microenvironment

Nature Reviews Clinical Oncology, 2021
Dean C Singleton, Andrew Macann, William R Wilson   +2 more
exaly  

Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

Nature Reviews Clinical Oncology, 2021
Elisabeth J M Huijbers, Judy R Van Beijnum, Patrycja Nowak-Sliwinska   +2 more
exaly  

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Nature Reviews Clinical Oncology, 2022
, Giedre Krenciute, Dimitrios L Wagner
exaly  

Tumour burden and efficacy of immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
Filippo Gustavo Dall'Olio, Aurelien Marabelle, Camilo Garcia   +2 more
exaly  

Circulating tumour DNA — looking beyond the blood

Nature Reviews Clinical Oncology, 2022
Ann Tivey, Matt Church, Natalie Cook
exaly  

The blood–tumour barrier in cancer biology and therapy

Nature Reviews Clinical Oncology, 2021
Patricia S Steeg
exaly  

Circulating tumour cells for early detection of clinically relevant cancer

Nature Reviews Clinical Oncology, 2023
, Klaus Pantel, Yong-Jie Lu
exaly